ADAR1 Capital Management »

Biomea Fusion shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Biomea Fusion (BMEA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Biomea Fusion

Tip: Access up to 7 years of quarterly data

All positions including Biomea Fusion held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomea Fusion by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $54k 43k 1.24

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Biomea Fusion

FMR
Vanguard Group
Aisling Capital Management
Woodline Partners
UBS Group
Marshall Wace
Susquehanna International
BlackRock
Fideuram - Intesa Sanpaolo Private Banking S.p.a.
Mariner Wealth Advisors
Two Sigma Investments
Geode Capital Management
Renaissance Technologies
Citadel Advisors
Federated Investors

View all funds holding Biomea Fusion